 DELRAY BEACH, Fla., March 10, 2021 GLOBE NEWSWIRE -- AzurRx BioPharma, Inc. AzurRx or the Company NASDAQ: AZRX, a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal GI diseases, announced today that James Sapirstein, Chairman and Chief Executive Officer, will present during the Maxim Group Emerging Growth Virtual Conference taking place Wednesday, March 17 to Thursday, March 18, 2021. All registered conference attendees will be able to view the prerecorded virtual presentation. 